Related Experiment Videos
Ranitidine administration in Henoch-Schönlein vasculitis
Acta Paediatrica Japonica : Overseas Edition
|February 1, 1995
Summary
This study found ranitidine significantly reduced abdominal pain and gastrointestinal bleeding in children with Henoch Schoenlein vasculitis (HSV). Ranitidine is a safe and effective treatment option for HSV patients experiencing GI symptoms.
Area of Science:
- Pediatric Gastroenterology
- Rheumatology
- Clinical Pharmacology
Background:
- Henoch Schoenlein vasculitis (HSV) is a common childhood vasculitis.
- Gastrointestinal (GI) bleeding and abdominal pain are significant complications of HSV.
- Limited treatment options exist for managing GI symptoms in HSV.
Purpose of the Study:
- To evaluate the efficacy of ranitidine in treating GI bleeding and abdominal pain in pediatric patients with Henoch Schoenlein vasculitis.
- To compare ranitidine's effectiveness against a placebo in managing HSV-related GI symptoms.
Main Methods:
- A randomized, placebo-controlled trial involving 12 pediatric patients diagnosed with Henoch Schoenlein vasculitis.
- Patients aged 6-14 years were divided into two groups, receiving either ranitidine or a placebo.
- Outcomes measured included the duration and severity of abdominal pain and GI bleeding.
Main Results:
- Ranitidine administration led to a statistically significant decrease in the duration and severity of abdominal pain and GI bleeding compared to placebo (P < 0.05).
- No adverse side effects were reported in the ranitidine group.
- The study demonstrated a clear benefit of ranitidine in alleviating GI manifestations of HSV.
Conclusions:
- Ranitidine is an effective and safe therapeutic option for managing gastrointestinal symptoms in children with Henoch Schoenlein vasculitis.
- The findings support the use of ranitidine as an adjunct treatment for pediatric HSV patients presenting with GI bleeding and pain.